271 related articles for article (PubMed ID: 37125252)
1. Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment.
Cox DRA; Chung W; Grace J; Wong D; Kutaiba N; Ranatunga D; Khor R; Perini MV; Fink M; Jones R; Goodwin M; Dobrovic A; Testro A; Muralidharan V
JGH Open; 2023 Apr; 7(4):249-260. PubMed ID: 37125252
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.
Guan MC; Ouyang W; Liu SY; Sun LY; Chen WY; Tong XM; Zhu H; Yang T
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):559-568. PubMed ID: 35643910
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A
Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of alpha-fetoprotein,
Song T; Wang L; Su B; Zeng W; Jiang T; Zhang T; Sun G; Wu H
J Int Med Res; 2020 Mar; 48(3):300060519889270. PubMed ID: 31852373
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
[TBL] [Abstract][Full Text] [Related]
7. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
Morimoto M; Numata K; Nozaki A; Kondo M; Moriya S; Taguri M; Morita S; Konno M; Sugo A; Miyajima E; Maeda S; Tanaka K
Int J Clin Oncol; 2012 Aug; 17(4):373-9. PubMed ID: 21847534
[TBL] [Abstract][Full Text] [Related]
8. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
9.
Lee HA; Lee YR; Lee YS; Jung YK; Kim JH; An H; Yim HJ; Jeen YT; Yeon JE; Byun KS; Seo YS
World J Gastroenterol; 2021 Jul; 27(28):4687-4696. PubMed ID: 34366629
[TBL] [Abstract][Full Text] [Related]
10. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.
Inagaki Y; Tang W; Makuuchi M; Hasegawa K; Sugawara Y; Kokudo N
Liver Int; 2011 Jan; 31(1):22-35. PubMed ID: 20874725
[TBL] [Abstract][Full Text] [Related]
12. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
[TBL] [Abstract][Full Text] [Related]
13. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
14. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
15. Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma.
Zane KE; Nagib PB; Jalil S; Mumtaz K; Makary MS
World J Hepatol; 2022 May; 14(5):885-895. PubMed ID: 35721283
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review.
Galanakis N; Kehagias E; Matthaiou N; Samonakis D; Tsetis D
Hepat Oncol; 2018 Apr; 5(2):HEP07. PubMed ID: 31293775
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Lai Q; Melandro F; Pinheiro RS; Donfrancesco A; Fadel BA; Levi Sandri GB; Rossi M; Berloco PB; Frattaroli FM
Int J Hepatol; 2012; 2012():893103. PubMed ID: 22792474
[TBL] [Abstract][Full Text] [Related]
18. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.
Song P; Gao J; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W
Liver Cancer; 2013 Jan; 2(1):31-9. PubMed ID: 24159594
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]